Alnylam Pharmaceuticals | ALNY - Action





Action Changement Date
Acadia Pharmaceuticals USD 31.57M 3.1M 2026-03
Agios Pharmaceuticals USD 35.09M 2.17M 2026-03
Alnylam Pharmaceuticals USD 200.15M 117.43M 2026-03
Amgen USD 6.19B 39M 2026-03
Arrowhead Research USD -173.08M 173.08M 2024-12
BioCryst Pharmaceuticals USD 5.98M 587K 2026-03
BioMarin Pharmaceutical USD 1.27B 25.66M 2026-03
Incyte USD 115.62M 14.56M 2026-03
Ionis Pharmaceuticals USD 5.56M 4.49M 2026-03
Moderna USD 146M 7M 2026-03
Neurocrine Biosciences USD 64.5M 4.5M 2026-03
Novartis USD 6.42B 114M 2025-09
PTC Therapeutics USD 75.57M 4.08M 2026-03
Regeneron Pharmaceuticals USD 3.1B 97.2M 2026-03
Sanofi EUR 22.69B 1.81B 2025-12
Sarepta Therapeutics USD 1B 86.37M 2026-03
Takeda JPY 1.41T 107.71B 2025-12
Ultragenyx Pharmaceutical USD 55M 3M 2026-03
Vertex Pharmaceuticals USD 1.77B 79.9M 2026-03